CN Stock MarketDetailed Quotes

603998 Hunan Fangsheng Pharmaceutical

Watchlist
  • 9.52
  • +0.05+0.53%
Market Closed Jan 17 15:00 CST
4.18BMarket Cap15.31P/E (TTM)

Hunan Fangsheng Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hunan Fangsheng Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.121B--
--2024/FY-- / 1.829B--
--2023/FY1.629B / 1.802B--
Mar 31, 20232022/FY1.792B / 1.877B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.121B--
--2024/FY-- / 1.829B--
--2023/FY1.629B / 1.802B--
Mar 31, 20232022/FY1.792B / 1.877B--
--------

Unlock Free Earnings Estimates

Hunan Fangsheng Pharmaceutical Earnings Reports

  • Fangsheng Pharmaceutical: Fangsheng Pharmaceutical Report for the Third Quarter of 2024

    Oct 28, 2024 12:00 ET

  • Fangsheng Pharmaceutical Report for the Third Quarter of 2024

    Oct 28, 2024 12:00 ET

  • Fangsheng Pharmaceutical\'s business data announcement for the first three quarters of 2024

    Oct 28, 2024 12:00 ET

  • Fangsheng Pharmaceutical 2024 Semi-Annual Report

    Aug 28, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 18, 2025

    Strong Buy

    • Strong Buy

      88.89%

    • Buy

      11.11%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Industrial Hemp
    Industrial Hemp
    Intraday+0.74%
    Innovative Drugs
    Innovative Drugs
    Intraday+0.64%
    The Concept of Old Age
    The Concept of Old Age
    Intraday+0.54%